Onglyza Problems

ACP Advice Aims to Cut Reliance on Onglyza and Invokana

onglyza and invokana

Diabetes drugs Onglyza and Invokana could be more trouble than they’re worth, according to new guidelines from one of the country’s most respected medical organizations. The American College of Physicians (ACP) has urged healthcare providers to exercise restraint when prescribing these and other popular diabetes medications. Specifically, the guidelines recommend restraint on prescriptions of costly SGLT2 and…

Read More